🔗 Visit the ClinicalTrials.gov page for NCT01335074
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. | Oncotarget | 2012 | 1.55 |
| 2 | Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. | J Hepatol | 2013 | 1.22 |
| 3 | Clinical trials in hepatocellular carcinoma: an update. | Liver Cancer | 2013 | 0.99 |
| 4 | Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR Inhibition. | Liver Cancer | 2012 | 0.98 |
| 5 | Molecular therapies in hepatocellular carcinoma: what can we target? | Dig Dis Sci | 2014 | 0.89 |
| 6 | Targeted therapies in the treatment of advanced hepatocellular carcinoma. | Clin Med Insights Oncol | 2013 | 0.83 |